Sunquest Announces Roper Technologies' Acquisition of CliniSys and Atlas Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Roper Industries (ROP) Reports Strong 3Q Results; UBS Raises Price target to $205
October 27, 2015 11:41 AM EDTUBS reiterated a Buy rating on Roper Industries (NYSE: ROP), and raised the price target to $205.00 (from $200.00), following the company's 3Q15 earnings results. Roper reported 3Q15 adjusted EPS of $1.61, above consensus of $1.57 and compared to guidance of $1.53-$1.57.
A UBS analyst commented, "Roper... More
